Analysis Life Sciences Thank You Workshop addresses oncology dose optimization across full span of development
Agency IQ
FEBRUARY 23, 2024
This workshop built on three prior workshops held by the FDA-AACR, which took place in 2015, 2016 and 2017. Whereas the prior workshops focused on certain types of therapies or the use of combination products, this newest workshop was designed to discuss “quantitative approaches to select dosages for clinical trials.”
40 
Let's personalize your content